Mg. Schlag et al., The effect of mannitol versus dimethyl thiourea at attenuating ischemia/reperfusion-induced injury to skeletal muscle, J VASC SURG, 29(3), 1999, pp. 511-521
Citations number
47
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Objective: Mannitol is used as a treatment for skeletal muscle ischemia/rep
erfusion (I/R) injury in humans, despite the fact that its effectiveness in
vivo is still disputed. The purpose of this study was to determine the eff
icacy of mannitol in attenuating I/R injury at the microcirculatory level.
Methods: The study was designed as an experimental study with male Wistar r
ats. The main outcome measures were intravital microscopy, which was used t
o measure capillary perfusion, capillary and venular red blood cell velocit
y (VRBC), and leukocyte-endothelial interactions in the extensor digitorum
longus muscle of the rat hind limb before and after ischemia. In addition,
tissue injury was assessed during reperfusion with the fluorescent vital dy
es bisbenzimide and ethidium bromide. Dimethyl thiourea (DMTU), a highly ef
fective therapeutic agent of experimental I/R injury, was used as a positiv
e control.
Results: No-flow ischemia (2 hour) resulted in a 40% drop in capillary perf
usion, a decline in capillary and venular VRBC, and increased leukocyte ven
ular adherence and tissue infiltration. Tissue injury increased to a consta
nt level during reperfusion. Mannitol attenuated capillary malperfusion dur
ing the first 60 minutes of reperfusion and prevented a decline in capillar
y VRBC. However, mannitol did not reduce tissue injury or leukocyte adheren
ce and infiltration during reperfusion. By comparison, DMTU not only preven
ted the perfusion deficits and the increases in leukocyte venular adherence
and tissue infiltration but significantly reduced the magnitude of tissue
injury.
Conclusion: Our findings suggest that mannitol may be of limited value for
the prevention of early reperfusion-induced injury after no-flow ischemia i
n skeletal muscle. By comparison, DMTU was highly efficacious by not only r
educing microvascular perfusion deficits but by also reducing leukocyte-end
othelial cell interactions and the incidence of cellular injury.